Studies focused on identifying specific genomic subtypes of bladder cancer unique to AA patients have found, for example, EGF containing fibrulin‐like extracellular matrix protein 1 (EFEMP1), S100 calcium binding protein A16 (S100Ar16), and myeloid cell leukemia 1 (MCL1) may be overexpressed in AA patients.25 Here, MCL1 is linked to urinary bladder cancer.